Humana Inc
HUM: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$552.00 | Sftmfxb | Jlxwwwrvq |
Humana Earnings: Elevated Medical Utilization Keeps Near-Term View Within Previous Range
Narrow-moat Humana turned in strong third-quarter results and maintained its near- and intermediate-term outlook, despite growing challenges such as increasing medical utilization in its core Medicare market. Given the stable outlook, our $550 fair value estimate does not look likely to change materially at first glance.